Ghrelin: A novel peptide with therapeutic effect in certain cancers?

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1157-1158

  Aydin, Suleyman ^a   Geckil, Hikmet ^b   Karaoglu, Aziz ^a   Elkiran, Emin Tamer ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GHRELIN; OCTREOTIDE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER; CELL PROLIFERATION; ESOPHAGEAL ADENOCARCINOMA; GENE DELETION; GROWTH HORMONE RELEASE; HUMAN; LETTER; PRIORITY JOURNAL;

GHRELIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 34548727296     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.027     Document Type: Letter

References (5)

1. Kojima M., and Kangawa K. Ghrelin structure and function. Physiol Rev 85 (2005) 495-522
2. Conconi M.T., Nico B., Guidolin D., et al. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides 12 (2004) 2179-2185
3. Baiguera S., Conconi M.T., Guidolin D., et al. Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 14 (2004) 849-854
4. Aydin S., Ozercan I.H., Dagli F., et al. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech Histochem 80 (2005) 163-168
5. Mottershead M, Karteris E, Barclay JY et al. Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma. J Clin Pathol, in press.